Posted On: 02/12/2016 2:09:02 PM
Post# of 1525
Great to see 3's, but this is still extremely undervalued based on previously reported financial information; so it's already a buy today.
Add in new revenue streams (340B) and acquisition news, both of which are expected in the near future, and fair value becomes more difficult to quantify without details of such upward catalysts.
Bottom line:
It's worth a lot more than .03 today, and it's worth a lot more than what it's worth today the moment additional news is published.
$RXMD is upside coated with upside.
Add in new revenue streams (340B) and acquisition news, both of which are expected in the near future, and fair value becomes more difficult to quantify without details of such upward catalysts.
Bottom line:
It's worth a lot more than .03 today, and it's worth a lot more than what it's worth today the moment additional news is published.
$RXMD is upside coated with upside.
(0)
(0)Scroll down for more posts ▼
